Breaking News Instant updates and real-time market news.

PDM

Piedmont Office Realty

$24.02 /

+0.47 (+2.00%)

16:34
02/04/20
02/04
16:34
02/04/20
16:34

Piedmont Office Realty reports Q4 core FFO 46c, consensus 45c

Reports Q4 revenue $134.15M, consensus $134.75M. Commenting on the quarter's results, Brent Smith, President and CEO, said, "2019 was a phenomenal year for Piedmont. We completed several key acquisitions which allowed us to gain control of the entire 2.1 million square foot Atlanta Galleria office development. Those acquisitions were funded by the sale of two of our more mature assets in non-strategic markets, including the sale during the fourth quarter of 500 West Monroe Street in Chicago, and demonstrate our ability to monetize assets which have maximized their growth potential in our portfolio and redeploy the proceeds accretively into our targeted sub-markets. Leasing activity for the year was an impressive 2.3 million square feet and resulted in strong current, and what we believe, will be future rent growth. During the fourth quarter we successfully completed an approximately 20-year renewal of one of our largest tenants, State of New York, for more space and at better economics than we originally anticipated. Further, we are very excited about the start we are seeing for 2020 with a significant acquisition planned in Dallas and continued leasing momentum across the portfolio."

  • 05

    Feb

PDM Piedmont Office Realty
$24.02 /

+0.47 (+2.00%)

01/06/20 Baird
Piedmont Office Realty upgraded to Outperform from Neutral at Baird
02/07/19 Stifel
Piedmont Office Realty upgraded to Hold on better value creation at Stifel
02/06/19 Stifel
Piedmont Office Realty upgraded to Hold from Sell at Stifel

TODAY'S FREE FLY STORIES

Hot Stocks
Weis Markets CFO Scott Frost to retire, Michael Lockard to succeed » 05:28
01/20/21
01/20
05:28
01/20/21
05:28
WMK

Weis Markets

$47.52 /

-0.97 (-2.00%)

Weis Markets announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse » 05:28
01/20/21
01/20
05:28
01/20/21
05:28
NVO

Novo Nordisk

$73.01 /

+0.99 (+1.37%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

01/15/21 Deutsche Bank
Novo Nordisk initiated with a Buy at Deutsche Bank
11/16/20 Piper Sandler
Piper says 'underwhelming' data from Novo Nordisk a 'big win' for Intercept
11/12/20 JPMorgan
Novo Nordisk price target lowered to DKK 470 from DKK 480 at JPMorgan
11/06/20 Morgan Stanley
Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley
NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

Downgrade
Schweiter downgraded to Add from Buy at Baader Helvea » 05:27
01/20/21
01/20
05:27
01/20/21
05:27
SCWTF

Schweiter

$0.00 /

+ (+0.00%)

Baader Helvea analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCWTF Schweiter
$0.00 /

+ (+0.00%)

05/26/20 UBS
Schweiter price target lowered to CHF 1,080 from CHF 1,200 at UBS
Upgrade
Boeing upgraded to Hold from Sell at Berenberg » 05:27
01/20/21
01/20
05:27
01/20/21
05:27
BA

Boeing

$210.66 /

+6.41 (+3.14%)

Berenberg analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

01/04/21
Fly Intel: Top five analyst downgrades
01/04/21 Baird
Boeing elevated to Fresh Pick at Baird
01/04/21 Bernstein
Bernstein downgrades Boeing to Underperform on worsening 787 outlook
01/04/21 Bernstein
Boeing downgraded to Underperform from Market Perform at Bernstein
BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

Downgrade
Gerdau downgraded to Hold from Buy at HSBC » 05:24
01/20/21
01/20
05:24
01/20/21
05:24
GGB

Gerdau

$4.76 /

-0.12 (-2.46%)

HSBC analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GGB Gerdau
$4.76 /

-0.12 (-2.46%)

01/12/21 Goldman Sachs
Gerdau downgraded to Neutral from Buy at Goldman Sachs
12/15/20 Morgan Stanley
Gerdau upgraded to Overweight from Equal Weight at Morgan Stanley
10/07/20 Bradesco BBI
Gerdau upgraded to Outperform from Neutral at Bradesco BBI
10/07/20 Bradesco BBI
Gerdau upgraded to Outperform from Neutral at Bradesco BBI
Downgrade
Grupo Financiero Banorte downgraded to Hold from Buy at HSBC » 05:22
01/20/21
01/20
05:22
01/20/21
05:22
GBOOF

Grupo Financiero Banorte

$0.00 /

+ (+0.00%)

HSBC analyst Carlos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBOOF Grupo Financiero Banorte
$0.00 /

+ (+0.00%)

10/27/20 Citi
Grupo Financiero Banorte downgraded to Neutral from Buy at Citi
10/13/20 Credit Suisse
Banorte upgraded to Outperform from Underperform at Credit Suisse
06/17/20 Goldman Sachs
Grupo Financiero Banorte initiated with a Buy at Goldman Sachs
05/14/20 Credit Suisse
Banorte downgraded to Underperform from Neutral at Credit Suisse
Hot Stocks
Alcon launches PRECISION1 contact lens in the U.S. » 05:22
01/20/21
01/20
05:22
01/20/21
05:22
ALC

Alcon

$72.68 /

+2.57 (+3.67%)

Alcon announced the U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$72.68 /

+2.57 (+3.67%)

ALC Alcon
$72.68 /

+2.57 (+3.67%)

01/07/21 KeyBanc
Veeva initiated with an Overweight at KeyBanc
11/19/20 Berenberg
Alcon price target raised to CHF 69 from CHF 62 at Berenberg
11/16/20 JPMorgan
Alcon price target raised to CHF 57 from CHF 55 at JPMorgan
11/12/20 Jefferies
Alcon price target raised to $78 from $71 at Jefferies
ALC Alcon
$72.68 /

+2.57 (+3.67%)

ALC Alcon
$72.68 /

+2.57 (+3.67%)

ALC Alcon
$72.68 /

+2.57 (+3.67%)

Upgrade
CK Infrastructure upgraded to Buy from Hold at HSBC » 05:22
01/20/21
01/20
05:22
01/20/21
05:22
CKISY

CK Infrastructure

$0.00 /

+ (+0.00%)

HSBC analyst Evan Li…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Banco Santander upgraded to Buy from Hold at HSBC » 05:21
01/20/21
01/20
05:21
01/20/21
05:21
SAN

Banco Santander

$3.29 /

+0.005 (+0.15%)

HSBC analyst Domenico…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

01/19/21 Barclays
Banco Santander price target raised to EUR 3.10 from EUR 2.90 at Barclays
01/15/21 Morgan Stanley
Banco Santander price target raised to EUR 3.50 from EUR 3.30 at Morgan Stanley
01/11/21 Deutsche Bank
Banco Santander price target raised to EUR 2.85 from EUR 2.80 at Deutsche Bank
01/11/21 UBS
Banco Santander upgraded to Buy from Neutral at UBS
SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

Downgrade
Arjo downgraded to Sell from Hold at Nordea » 05:20
01/20/21
01/20
05:20
01/20/21
05:20
ARRJF

Arjo

$0.00 /

+ (+0.00%)

Nordea analyst Sten…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Amryt receives NICE approval for Myalepta reimbursement in England, Wales » 05:19
01/20/21
01/20
05:19
01/20/21
05:19
AMYT

Amryt Pharma

$13.49 /

+ (+0.00%)

Amryt announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMYT Amryt Pharma
$13.49 /

+ (+0.00%)

AMYT Amryt Pharma
$13.49 /

+ (+0.00%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
Upgrade
Daimler AG upgraded to Buy from Hold at HSBC » 05:19
01/20/21
01/20
05:19
01/20/21
05:19
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

HSBC analyst Henning…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

01/14/21 R.F. Lafferty
Luminar initiated with a Buy at R.F. Lafferty
01/08/21 Deutsche Bank
Daimler AG named short-term investment idea at Deutsche Bank
01/07/21 Deutsche Bank
Daimler AG price target raised to EUR 70 from EUR 60 at Deutsche Bank
11/27/20 Exane BNP Paribas
Exane double upgrades Daimler on Mercedes electric car potential
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Hot Stocks
Calliditas Therapeutics to provide data from Part A of NefIgArd study » 05:17
01/20/21
01/20
05:17
01/20/21
05:17
CALT

Calliditas Therapeutics

$31.90 /

+1.35 (+4.42%)

Calliditas Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALT Calliditas Therapeutics
$31.90 /

+1.35 (+4.42%)

CALT Calliditas Therapeutics
$31.90 /

+1.35 (+4.42%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
  • 05
    Jun
Downgrade
Elkem ASA downgraded to Hold from Buy at DNB Markets » 05:17
01/20/21
01/20
05:17
01/20/21
05:17
ELKEF

Elkem ASA

$0.00 /

+ (+0.00%)

DNB Markets analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELKEF Elkem ASA
$0.00 /

+ (+0.00%)

06/24/20 Citi
Elkem ASA downgraded to Sell from Neutral at Citi
03/30/20 Morgan Stanley
Elkem ASA price target lowered to NOK 17 from NOK 21 at Morgan Stanley
Upgrade
Cairn Energy upgraded to Add from Hold at Peel Hunt » 05:16
01/20/21
01/20
05:16
01/20/21
05:16
CRNCY

Cairn Energy

$0.00 /

+ (+0.00%)

Peel Hunt analyst Werner…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNCY Cairn Energy
$0.00 /

+ (+0.00%)

01/12/21 Morgan Stanley
Cairn Energy price target raised to 250 GBp from 248 GBp at Morgan Stanley
01/11/21 RBC Capital
Cairn Energy price target raised to 300 GBp from 150 GBp at RBC Capital
01/11/21 Barclays
Cairn Energy price target raised to 315 GBp from 235 GBp at Barclays
12/24/20 AlphaValue
Cairn Energy upgraded to Add from Sell at AlphaValue
Upgrade
Trainline upgraded to Buy from Hold at Panmure Gordon » 05:15
01/20/21
01/20
05:15
01/20/21
05:15
TNLIY

Trainline

$0.00 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNLIY Trainline
$0.00 /

+ (+0.00%)

01/19/21 Deutsche Bank
Trainline price target lowered to 512 GBp from 527 GBp at Deutsche Bank
12/10/20 JPMorgan
Trainline price target raised to 486 GBp from 430 GBp at JPMorgan
12/03/20 Stifel
Trainline initiated with a Buy at Stifel
10/19/20 Deutsche Bank
Trainline initiated with a Buy at Deutsche Bank
Downgrade
Crown Resorts downgraded to Neutral from Outperform at Credit Suisse » 05:13
01/20/21
01/20
05:13
01/20/21
05:13
CWLDF

Crown Resorts

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Netflix upgraded to Overweight from Equal Weight at Wells Fargo » 05:11
01/20/21
01/20
05:11
01/20/21
05:11
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

05:01 Today Piper Sandler
Netflix price target raised to $652 from $643 at Piper Sandler
04:52 Today Pivotal Research
Netflix price target raised to $750 from $660 at Pivotal Research
04:41 Today UBS
Netflix upgraded to Buy from Neutral at UBS
01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Downgrade
Bloom Energy downgraded to Neutral from Outperform at Credit Suisse » 05:06
01/20/21
01/20
05:06
01/20/21
05:06
BE

Bloom Energy

$39.89 /

+3.41 (+9.35%)

Credit Suisse analyst…

Credit Suisse analyst Michael Weinstein downgraded Bloom Energy to Neutral from Outperform with a price target of $32, up from $27. The stock closed Tuesday up 9% to $39.93. The analyst increased the price target to reflect higher 2024 and 2025 growth rates due to a two year federal solar tax credit extension and potentially favorable zero-carbon policy under President Biden. Weinstein, however, downgrades Bloom due to valuation.

ShowHide Related Items >><<
BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

01/14/21 JPMorgan
Bloom Energy price target raised to $35 from $26 at JPMorgan
01/12/21 Morgan Stanley
Morgan Stanley downgrades 2020 top performer Bloom Energy to Equal Weight
01/12/21 Morgan Stanley
Bloom Energy downgraded to Equal Weight from Overweight at Morgan Stanley
12/21/20 Morgan Stanley
Bloom Energy price target raised to $32 from $21 at Morgan Stanley
BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

  • 15
    Oct
  • 02
    Oct
BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

Upgrade
Megaport upgraded to Buy from Neutral at Goldman Sachs » 05:03
01/20/21
01/20
05:03
01/20/21
05:03
MGPPF

Megaport

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGPPF Megaport
$0.00 /

+ (+0.00%)

MGPPF Megaport
$0.00 /

+ (+0.00%)

08/06/20 Canaccord
Megaport upgraded to Buy from Hold at Canaccord
Recommendations
Netflix price target raised to $652 from $643 at Piper Sandler » 05:01
01/20/21
01/20
05:01
01/20/21
05:01
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

04:52 Today Pivotal Research
Netflix price target raised to $750 from $660 at Pivotal Research
04:41 Today UBS
Netflix upgraded to Buy from Neutral at UBS
01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Downgrade
ShockWave Medical downgraded to Neutral from Overweight at Piper Sandler » 05:00
01/20/21
01/20
05:00
01/20/21
05:00
SWAV

ShockWave Medical

$142.06 /

+5 (+3.65%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$142.06 /

+5 (+3.65%)

SWAV ShockWave Medical
$142.06 /

+5 (+3.65%)

01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
01/12/21 Wells Fargo
ShockWave Medical price target raised to $134 from $95 at Wells Fargo
12/03/20 Piper Sandler
Piper boosts ShockWave Medical target to $96, likes setup into 2021
12/02/20 Oppenheimer
Oppenheimer stays at Perform on ShockWave, highlights paper on IVL-induced VFib
SWAV ShockWave Medical
$142.06 /

+5 (+3.65%)

  • 17
    Jun
Downgrade
Global Blood downgraded to Neutral from Overweight at Piper Sandler » 04:58
01/20/21
01/20
04:58
01/20/21
04:58
GBT

Global Blood Therapeutics

$50.81 /

+0.83 (+1.66%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$50.81 /

+0.83 (+1.66%)

GBT Global Blood Therapeutics
$50.81 /

+0.83 (+1.66%)

12/15/20 H.C. Wainwright
Global Blood Therapeutics assumed with a Buy at H.C. Wainwright
12/03/20
Fly Intel: Top five analyst initiations
12/03/20 RBC Capital
Global Blood Therapeutics initiated with an Outperform at RBC Capital
11/18/20 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $120 from $133 at Cantor Fitzgerald
GBT Global Blood Therapeutics
$50.81 /

+0.83 (+1.66%)

GBT Global Blood Therapeutics
$50.81 /

+0.83 (+1.66%)

Recommendations
Omnicell price target raised to $140 from $125 at Benchmark » 04:57
01/20/21
01/20
04:57
01/20/21
04:57
OMCL

Omnicell

$121.56 /

+0.71 (+0.59%)

Benchmark analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OMCL Omnicell
$121.56 /

+0.71 (+0.59%)

OMCL Omnicell
$121.56 /

+0.71 (+0.59%)

01/14/21 Craig-Hallum
Omnicell price target raised to $142 from $100 at Craig-Hallum
12/09/20 Piper Sandler
Pontential Baxter, Omnicell deal makes sense, says Piper Sandler
12/09/20 Benchmark
Omnicell price target raised to $125 from $100 at Benchmark
12/08/20 Berenberg
Berenberg starts four healthcare technology companies with Buy ratings
OMCL Omnicell
$121.56 /

+0.71 (+0.59%)

OMCL Omnicell
$121.56 /

+0.71 (+0.59%)

OMCL Omnicell
$121.56 /

+0.71 (+0.59%)

Upgrade
Lumentum upgraded to Buy from Neutral at Goldman Sachs » 04:55
01/20/21
01/20
04:55
01/20/21
04:55
LITE

Lumentum

$94.50 /

-11.69 (-11.01%)

, COHR

Coherent

$197.01 /

+45.09 (+29.68%)

Goldman Sachs analyst Rod…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LITE Lumentum
$94.50 /

-11.69 (-11.01%)

COHR Coherent
$197.01 /

+45.09 (+29.68%)

LITE Lumentum
$94.50 /

-11.69 (-11.01%)

01/19/21 Craig-Hallum
Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
01/12/21 MKM Partners
Lumentum price target raised to $138 from $120 at MKM Partners
01/12/21 Susquehanna
Susquehanna names top five M&A candidates in Semi space
01/11/21 B. Riley Securities
Lumentum price target raised to $123 from $101 at B. Riley Securities
COHR Coherent
$197.01 /

+45.09 (+29.68%)

01/19/21 Craig-Hallum
Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
01/12/21 Barclays
Coherent downgraded to Underweight from Equal Weight at Barclays
11/12/20 Longbow
Coherent downgraded to Neutral ahead of transition year at Longbow
11/12/20 Longbow
Coherent downgraded to Neutral from Buy at Longbow
LITE Lumentum
$94.50 /

-11.69 (-11.01%)

COHR Coherent
$197.01 /

+45.09 (+29.68%)

LITE Lumentum
$94.50 /

-11.69 (-11.01%)

COHR Coherent
$197.01 /

+45.09 (+29.68%)

LITE Lumentum
$94.50 /

-11.69 (-11.01%)

COHR Coherent
$197.01 /

+45.09 (+29.68%)

LITE Lumentum
$94.50 /

-11.69 (-11.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.